|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01099 SINOPHARM
Nominal 
15.930 +0.120 (+0.759%) Ranking Overview
Ranking based on 10 research report(s)
Average Ranking 2.30
|
Strong Buy (1)
0
|
Buy (2)
7
|
Hold (3)
3
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | 229.00 RMB (cts) | |
| Net Profit | 7,155.09 RMB (MIL) | DPS | 69.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2026 | 7,377.35 | 236.50 | 73.00 | -- | 7,702.00 | 6,570.00 |
| 2027 | 7,857.00 | 251.90 | 76.00 | -- | 8,496.00 | 6,964.00 |
| 2028 | 8,437.00 | 270.40 | 82.05 | -- | 9,197.00 | 7,734.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 7,545.00 | 242.00 | 73.00 | UBS | Buy | 25.70 | 23/03/2026 | |
| 2026 | 7,526.00 | 241.00 | 73.00 | CICC | Outperform | 24.70 | 25/08/2026 | |
| 2026 | 7,702.00 | 247.00 | 74.91 | MORGAN STANLEY | Overweight | 23.00 | 24/08/2026 | |
| 2026 | 7,694.00 | 246.50 | 73.10 | CLSA | OutPerform | 21.10 | 25/08/2026 | |
| 2026 | 7,324.00 | 235.00 | -- | CITIC SEC | Buy | 21.00 | 01/07/2026 | |
| 2026 | 7,188.00 | 230.00 | 82.30 | BANK OF AMERICA | Buy | 20.50 | 24/08/2026 | |
| 2026 | 7,248.00 | 232.30 | 69.60 | CITIGROUP | Buy | 20.40 | 25/08/2026 | |
| 2026 | 7,430.70 | 238.00 | 71.00 | GOLDMAN SACHS | Neutral | 19.83 | 23/03/2026 | |
| 2026 | 6,570.00 | 210.50 | 63.40 | DAIWA | Hold | 17.00 | 24/08/2026 | |
| 2026 | 7,229.50 | 231.70 | 69.62 | UOB | Hold | 17.00 | 28/04/2026 | |
| 2027 | 7,964.00 | 255.00 | 77.00 | UBS | -- | -- | 23/03/2026 | |
| 2027 | 7,918.00 | 254.00 | 76.00 | CICC | -- | -- | 25/08/2026 | |
| 2027 | 8,496.00 | 272.00 | 82.11 | MORGAN STANLEY | -- | -- | 24/08/2026 | |
| 2027 | 8,218.00 | 263.30 | 78.10 | CLSA | -- | -- | 25/08/2026 | |
| 2027 | 8,272.00 | 265.00 | -- | CITIC SEC | -- | -- | 01/07/2026 | |
| 2027 | 7,373.00 | 236.00 | 90.50 | BANK OF AMERICA | -- | -- | 24/08/2026 | |
| 2027 | 7,796.00 | 249.80 | 74.90 | CITIGROUP | -- | -- | 25/08/2026 | |
| 2027 | 7,603.70 | 244.00 | 73.00 | GOLDMAN SACHS | -- | -- | 23/03/2026 | |
| 2027 | 6,964.00 | 223.20 | 67.20 | DAIWA | -- | -- | 24/08/2026 | |
| 2027 | 7,660.70 | 245.50 | 74.48 | UOB | -- | -- | 28/04/2026 | |
| 2028 | 8,589.00 | 275.00 | 83.00 | UBS | -- | -- | 23/03/2026 | |
| 2028 | 8,767.00 | 281.00 | 84.99 | MORGAN STANLEY | -- | -- | 24/08/2026 | |
| 2028 | 9,000.00 | 288.40 | 85.50 | CLSA | -- | -- | 25/08/2026 | |
| 2028 | 9,197.00 | 295.00 | -- | CITIC SEC | -- | -- | 01/07/2026 | |
| 2028 | 7,801.00 | 250.00 | 99.60 | BANK OF AMERICA | -- | -- | 24/08/2026 | |
| 2028 | 8,437.00 | 270.40 | 81.10 | CITIGROUP | -- | -- | 25/08/2026 | |
| 2028 | 7,819.60 | 251.00 | 75.00 | GOLDMAN SACHS | -- | -- | 23/03/2026 | |
| 2028 | 7,734.00 | 247.80 | 74.60 | DAIWA | -- | -- | 24/08/2026 | |
| 2028 | 8,149.00 | 261.10 | 79.34 | UOB | -- | -- | 28/04/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 28/08/2026 18:00 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 3,403,773 |
| %Change | -1.786% |
| EPS / (LPS) | RMB 1.090 |
| NBV Per Share (¥) | RMB 27.300 |